A Multicenter Prospective Study of High Risk Molecular Typing in Patients With Adult T Lymphoblastic Lymphoma

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04320992

Enrollment

207

Registered

2020-03-25

Start date

2020-03-31

Completion date

2023-03-31

Last updated

2020-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T-Lymphoblastic Lymphoma/Leukemia

Brief summary

The purpose of this study is to determine the indicative value of high risk molecular typing in patients with adult T lymphoblastic lymphoma

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* biopsy proved T lymphoblastic lymphoma * newly diagnosed patients

Exclusion criteria

* patients with biopsy samples unavailable

Design outcomes

Primary

Measure	Time frame
progression free survival	3-years

Countries

China

Contacts

Primary ContactQing qing Cai, MD

caiqq@sysucc.org.cn0086-20-87342823

Outcome results